198 related articles for article (PubMed ID: 35971888)
1. Clinical role of ambulatory reflux monitoring in PPI non-responders: recommendation statements.
Yadlapati R; Gawron AJ; Gyawali CP; Chen J; Clarke J; Fass R; Jain A; Lynch K; Khan A; Katz PO; Katzka DA; Richter J; Schnoll-Sussman F; Spechler SJ; Vaezi MF; Vela M; Pandolfino JE
Aliment Pharmacol Ther; 2022 Oct; 56(8):1274-1283. PubMed ID: 35971888
[TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
Yadlapati R; Gyawali CP; Pandolfino JE;
Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial.
Yadlapati R; Masihi M; Gyawali CP; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE
Gastroenterology; 2021 Jan; 160(1):174-182.e1. PubMed ID: 32949568
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
5. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.
Gyawali CP; Tutuian R; Zerbib F; Rogers BD; Frazzoni M; Roman S; Savarino E; de Bortoli N; Vela MF; Sifrim D
Gastroenterology; 2021 Nov; 161(5):1412-1422. PubMed ID: 34270955
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles.
Yadlapati R; Tye M; Keefer L; Kahrilas PJ; Pandolfino JE
Am J Gastroenterol; 2018 Jan; 113(1):31-38. PubMed ID: 28895583
[TBL] [Abstract][Full Text] [Related]
7. Applying Lyon Consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn.
Frazzoni M; Frazzoni L; Ribolsi M; Bortoli N; Tolone S; Russo S; Conigliaro R; Penagini R; Fuccio L; Zagari RM; Savarino E
Aliment Pharmacol Ther; 2022 Jun; 55(11):1423-1430. PubMed ID: 35229321
[TBL] [Abstract][Full Text] [Related]
8. Latin American consensus on diagnosis of gastroesophageal reflux disease.
Olmos JA; Pandolfino JE; Piskorz MM; Zamora N; Valdovinos Díaz MA; Remes Troche JM; Guzmán M; Hani A; Valdovinos García LR; Pitanga Lukashok H; Domingues G; Vesco E; Rivas MM; Ovalle LFP; Cisternas D; Vela MF
Neurogastroenterol Motil; 2024 Mar; 36(3):e14735. PubMed ID: 38225792
[TBL] [Abstract][Full Text] [Related]
9. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
[TBL] [Abstract][Full Text] [Related]
10. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M
Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
[TBL] [Abstract][Full Text] [Related]
11. On-therapy impedance-pH monitoring can efficiently characterize PPI-refractory GERD and support treatment escalation.
Frazzoni M; Frazzoni L; Ribolsi M; Russo S; Conigliaro R; De Bortoli N; Savarino E
Neurogastroenterol Motil; 2023 May; 35(5):e14547. PubMed ID: 36780512
[TBL] [Abstract][Full Text] [Related]
12. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
Patel A; Sayuk GS; Kushnir VM; Chan WW; Gyawali CP
Neurogastroenterol Motil; 2016 Apr; 28(4):513-21. PubMed ID: 26686239
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.
Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M
Digestion; 2020; 101(2):174-183. PubMed ID: 30897577
[TBL] [Abstract][Full Text] [Related]
14. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
Triadafilopoulos G; Kamal A; Clarke JO
Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36567531
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic measurement of gastric pH associates with persistent acid reflux in patients treated with proton-pump inhibitors for gastroesophageal reflux disease.
Januszewicz W; Hartley J; Waldock W; Roberts G; Alias B; Hobson A; Wernisch L; di Pietro M
United European Gastroenterol J; 2019 Dec; 7(10):1389-1398. PubMed ID: 31807307
[TBL] [Abstract][Full Text] [Related]
16. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
17. Optimal Wireless Reflux Monitoring Metrics to Predict Discontinuation of Proton Pump Inhibitor Therapy.
Yadlapati R; Gyawali CP; Masihi M; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE
Am J Gastroenterol; 2022 Oct; 117(10):1573-1582. PubMed ID: 35973148
[TBL] [Abstract][Full Text] [Related]
18. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic work-up of GERD.
Vela MF
Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):655-66. PubMed ID: 25216910
[TBL] [Abstract][Full Text] [Related]
20. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
